GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

GLP-1 Drugs Linked to Cognitive Impairment, Though the Reason Why Probably Isn't What You Expect

Extensive research has shown that glucagon-like peptide-1 (GLP-1) agonist drugs like semaglutide, the active ingredient in Ozempic, appear to have a constellation of different health benefits beyond the treatment of diabetes and weight loss. In addition to cutting the progression kidney disease, lowering the risk of opiate addiction and prolonging life expectancy, studies have shown that the drugs even seem to reduce the risk of cognitive impair…